ENvue Medical Inc.
FEED | NASDAQ
$1.03
$0.00 (0.00%)
Nov 2, 2026, 12:48 PM ET · Market open
Market Data
Market Cap $951.43K
Enterprise Value $1.12M
Beta 1.56
Average Volume 105.52K
Shares Outstanding (Diluted) 513.1K
Shares Change YoY 12606.88%
Institutional Ownership 4.73%
Exchange NASDAQ
ISIN US63008J8760
Price Performance
Price Change 1M -69.3%
Price Change 3M -79.8%
Price Change 6M -95.0%
Price Change YTD -96.3%
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -91.2%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR -99.6%
Valuation
PE Ratio -0.00
Forward PE N/A
PEG Ratio 0.00
Forward PEG -0.00
PS Ratio 0.49
Forward PS 2.50
PB Ratio 0.03
P/FCF Ratio -0.08
P/Adj. FCF Ratio -0.08
P/OCF Ratio -0.05
EV/Sales 0.58
EV/EBIT -0.07
EV/EBITDA -0.08
EV/FCF -0.10
Earnings Yield -8034675.7%
FCF Yield -1234.3%
Adj. FCF Yield -1234.3%
Financial Health
Net Debt $101K
Total Debt $1.31M
Cash & Short-Term Investments $1.14M
Total Assets $38.41M
Current Ratio 0.66
Quick Ratio 0.31
Debt / Equity Ratio 0.04
Debt / EBITDA -0.09
Debt / FCF -0.11
OCF / Debt -8.89
Interest Coverage -61.10
Altman Z-Score -5.82
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin -26.1%
Operating Profit Margin -783.6%
EBITDA Margin -749.8%
Net Profit Margin -1088.9%
FCF Margin -609.8%
Adj. FCF Margin -609.8%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -54.6%
Return on Equity -60.5%
Return on Invested Capital -45.9%
Return on Capital Employed -48.5%
Return on Tangible Assets -391.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 37.3%
Revenue CAGR 5Y 25.8%
Revenue CAGR 10Y 33.0%
EPS CAGR 3Y -141.2%
EPS CAGR 5Y -72.5%
EPS CAGR 10Y 23.2%
FCF CAGR 3Y -84.6%
FCF CAGR 5Y -36.5%
FCF CAGR 10Y -12.3%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 32.6%
Revenue Growth Next 3Y -11.5%
Earnings Date Nov 17, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.65
Price Target Upside 351.5%
Cash Flow
Operating Cash Flow $-11.65M
Free Cash Flow $-11.74M
Adj. Free Cash Flow $-11.74M
FCF Per Share -$22.89
OCF Per Share -$22.70
OCF/S Ratio -604.8%
Income Statement
Revenue $1.93M
Gross Profit $-502K
Operating Income $-15.09M
EBITDA $-14.44M
Net Income $-20.97M
EPS (Diluted) -$82,757
Revenue / Employee $148.15K
Profit / Employee $-1.61M
Employees 13
Add to Watchlist
Select watchlists to add or remove FEED